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Leishmania guyanensis
suppressed inducible nitric
oxide synthase provoked by its
viral endosymbiont
Dmitry Kopelyanskiy 1, Chantal Desponds 1, Florence Prevel 1,
Matteo Rossi 1, Romain Migliorini 1, Tiia Snäkä 1,
Remzi Onur Eren 1,2, Stéphanie Claudinot 1, Lon-Fye Lye 3,
Manolis Pasparakis 2, Stephen M. Beverley 3 and Nicolas Fasel 1*
1
Department of Biochemistry, University of Lausanne, Epalinges, Switzerland, 2 Institute for Genetics,
Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD)
and Center for Molecular Medicine, University of Cologne, Cologne, Germany, 3 Department of
Molecular Microbiology, School of Medicine, Washington University, St. Louis, MO, United States

Inducible nitric oxide synthase (iNOS) is essential to the production of nitric
oxide (NO), an efﬁcient effector molecule against intracellular human
pathogens such as Leishmania protozoan parasites. Some strains of
Leishmania are known to bear a viral endosymbiont termed Leishmania RNA
virus 1 (LRV1). Recognition of LRV1 by the innate immune sensor Toll-like
receptor-3 (TLR3) leads to conditions worsening the disease severity in mice.
This process is governed by type I interferon (type I IFNs) arising downstream of
TLR3 stimulation and favoring the formation of secondary metastatic lesions.
The formation of these lesions is mediated by the inﬂammatory cytokine IL-17A
and occurs in the absence, or low level of, protective cytokine IFN-g. Here, we
described that the presence of LRV1 led to the initial expression of iNOS and
low production of NO that failed to control infection. We subsequently showed
that LRV1-triggered type I IFN was essential but insufﬁcient to induce robust
iNOS induction, which requires strong activation of nuclear factor kappa-lightchain-enhancer of activated B cells (NF-kB). Leishmania guyanensis carrying
LRV1 (LgyLRV1+) parasites mitigated strong iNOS production by limiting NF-kB
activation via the induction of tumor necrosis factor-alpha-induced protein 3
(TNFAIP3), also known as A20. Moreover, our data suggested that production of
LRV1-induced iNOS could be correlated with parasite dissemination and
metastasis via elevated secretion of IL-17A in the draining lymph nodes. Our
ﬁndings support an additional strategy by which LRV1-bearing Leishmania
guyanensis evaded killing by nitric oxide and suggest that low levels of LRV1induced NO might contribute to parasite metastasis.
KEYWORDS

Leishmania, Leishmania RNA virus 1 (LRV1), type I Interferons, nuclear factor kappalight-chain-enhancer of activated B cells (NF-kB), inducible nitric oxide synthase
(iNOS), tumor necrosis factor-alpha-induced protein 3 (A20), IL-17A, metastasis
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Upon inoculation, parasites are engulfed by tissue resident
macrophages, where they convert into the round amastigote
form. Leishmania survive and proliferate inside the
macrophages causing different types of pathologies depending
on the infecting species and immune competence of the host.
Termed leishmaniasis, this range of diseases affects over 12
million people in 98 countries worldwide (Kaye and Scott,
2011; Alvar et al., 2014). Mucocutaneous leishmaniasis (MCL)
and disseminated cutaneous leishmaniasis (DCL) develop
mainly due to infection with species of Leishmania Viannia
subgenus, such as Leishmania guyanensis (Lgy) and Leishmania
brasiliensis (Lbr). These pathologies arise as complications of
cutaneous leishmaniasis (CL) and are characterized by
metastatic lesions coming from primary sites of infection to
the mucosal nasopharyngeal tissues in the case of MCL, and
other skin areas in the case of DCL.
In some cases, parasites bear a cytoplasmic double stranded
RNA (dsRNA) virus termed Leishmania RNA virus (LRV).
There are two known subgenera of LRVs. LRV1 has been
found in New World species such as Lgy (Tarr et al., 1988)
and Lbr (Zangger et al., 2013), while another species of LRV,
termed LRV2 has been found in Old World L. major (Scheffter
et al., 1994), L. aethiopica (Zangger et al., 2014) and L. infantum
(Hajjaran et al., 2016). The difference between LRV1 and LRV2
lies within the genetic organization and replication mechanisms
(Lee et al., 1996; Se et al., 2005; Fujimura and Esteban, 2011;
Kostygov et al., 2021).
Although the existence of such endoprotozoan viruses of the
Totiviridae family have been discovered and described almost 30
years ago (Tarr et al., 1988; Stuart et al., 1992; Weeks et al., 1992),
their role in disease progression remained elusive for years. It is
now known that upon its release from dying parasites or possibly
due to exosomal transfer (Atayde et al., 2019; Olivier and
Zamboni, 2020), this viral endosymbiont is recognized by
endosomal TLR3, leading to increased production of proinﬂammatory cytokines and chemokines. Paradoxically, this
TLR3-mediated innate response exacerbates the disease as
mice infected with LRV1-bearing Lgy (LgyLRV1+) develop
higher lesions and display more parasite burden at the peak of
infection when compared to their LRV1-negative counterparts
(LgyLRV1-) (Ives et al., 2011). In part this phenomenon is
explained by the activation of Akt-dependent pro-survival
mechanisms within the host macrophage. Prolonged survival
of infected cells promotes parasite persistence, therefore
contributing to the exacerbated phenotype (Eren et al., 2016).
We recently showed that LRV1-dependent dissemination and
formation of metastatic lesions is linked to low levels of IFN-g
and is mediated by IL-17A (Hartley et al., 2016). Clinical
signiﬁcance of LRV1 presence within Leishmania parasites
relies on the selection of correct treatment schemes. We and
others recently described that patients, diagnosed with MCL and
DCL, caused by LgyLRV1+ or LbrLRV1+, require prolonged

Introduction
Inducible nitric oxide synthases (iNOS) is a member of a
family of three enzymes responsible for conversion of L-arginine
to L-citrulline, an important metabolic process accompanied by
the release of nitric oxide (NO). Unlike endothelial NOS (eNOS)
and neuronal NOS (nNOS), two constitutively expressed Ca2+
dependent isoforms, expression of iNOS does not require Ca2+
intake and does not occur in resting cells. Several inﬂammatory
stimuli can trigger iNOS expression and the production of large
amounts of NO. This molecule has many different functions and
was described, amongst others, to have regulatory effects on
angiogenesis, tumor metastasis and cell adhesion (Bogdan,
2015). Most importantly, NO plays a crucial role in the
immune protection against intracellular pathogens as it is
directly responsible for their elimination. Thus, iNOS is the
key player mediating the immune response to many
microbial infections.
Toll-like receptors (TLRs) are the most known and bestcharacterized family of pattern-recognition receptors (PRRs)
(Akira et al., 2006). They play a crucial role in detection of
pathogenic intruders. TLRs initiate microbial clearance and
production of pro-inﬂammatory effector cytokines and
chemokines that further direct the adaptive immune response
(Majewska and Szczepanik, 2006). Most of the TLRs signal via
the myeloid differentiation primary response protein 88
(MyD88), whilst TLR3 is the only TLR that acts solely via the
TIR-inducing IFN-b (TRIF) molecule. TRIF signaling promotes
an antiviral innate response via activation of the interferon
regulatory factor 3 (IRF-3), which leads to the transcription of
type I interferons (type I IFNs). Both MyD88 and TRIF signaling
cascades lead to the nuclear translocation of the nuclear factor
kappa-light-chain-enhancer of activated B cells (NF-kB) and
activator protein-1 (AP-1) transcription factors.
NF-kB is the key player in inﬂammation and immunity. This
complex encompasses ﬁve different members containing the Rel
homology domain: NF-kB1 (p105/p50), NF-kB2 (p100/p52),
RelA (p65), RelB and c-Rel (Hoffmann et al., 2006). The most
abundant member is the p65p50 heterodimer (Hayden and
Ghosh, 2012) which is usually associated with activation of
transcription. This in turn leads to the consequent
transcription of pro-inﬂammatory cytokines, such as tumor
necrosis factor alpha (TNF-a) and Interleukin 6 (IL-6) (Kawai
and Akira, 2006). As a major negative feedback regulator of NFkB-mediated inﬂammation, tumor necrosis factor alphainduced protein 3 (TNFAIP3) (also named A20) is induced
very early in the NF-kB response (Coornaert et al., 2009;
Catrysse et al., 2014).
Leishmania is a genus of protozoan parasites that exists in
two morphological forms. The ﬂagellated promastigote forms
are transmitted by a sand ﬂy vector to the mammalian hosts.
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Ifn-g-/- (B6.129S7-Ifng tm1Ts/J)and Inos-/- (B6.129P2-Nos2
tm1Lau/J) mice were purchased from The Jackson Laboratory.
Ifn-g-/-Inos-/- DKO mice were produced by intercrossing Ifn-g-/and Inos-/- mice. Mice were kept and bred in Green Line cages
(Tecniplast) at the animal facility of the Center of Immunity and
Immunology, Lausanne (CIIL, Switzerland) in a speciﬁc
pathogen-free environment. Experiments were performed at a
biosafety level 2 (BSL-2) animal facility at the CIIL after one
week of acclimatization, in disposable cages (Innovive). Cages
were enriched with one igloo, two carboard tubes, one wood
stick, and tissues. Males and females were used. In both
husbandries, food (SAFE or KLIBA NAFAG) and water were
provided ad libitum. Light cycle was maintained at 13 hours light
and 11 hours darkness, temperature was set at 21°C ± 2 and
humidity was kept at 55% ± 10. Ifn-g-/-Inos-/- DKO and A20ﬂ/
ﬂLySMCre/wt mice were genotyped by PCR on tissue-isolated
genomic DNA using the 124 KAPA Mouse Genotyping Kit
(KAPA Biosystems, USA) using primers shown in
Supplementary Table 1.

therapy and are more prone to relapse upon treatment (Adaui
et al., 2015; Bourreau et al., 2015). We further identiﬁed that type
I IFNs, induced downstream of TLR3 signaling, either by LRV1,
or co-infecting viruses, are the key molecules that contribute
directly to the exacerbated disease phenotype (Rossi et al., 2017).
Being an extremely successful pathogen, Leishmania has
developed various strategies to evade the host immune
response. These include, facilitating its own capture by the
host cells and resisting the internal hostile environment
together with subverting various signaling pathways and
exploiting immune mechanisms in order to facilitate its own
survival and progression, thus making Leishmania one of the
most insidious pathogens (Gupta et al., 2013; Rossi and Fasel,
2018). Some examples describe various strains of Leishmania
promoting host-cell A20 induction and therefore evading
inﬂammatory reactions as well as suppressing inﬂammasome
activation (Srivastav et al., 2012; Gupta et al., 2017; Hartley
et al., 2018).
In the case of LgyLRV1+ infection, viral dsRNA serves as an
additional potent immunogen, whose recognition triggers a
plethora of signaling cascades. Herein we described how
LgyLRV1+ infection initiates a parasiticidal signaling pathway.
Consequently, we showed how parasites mitigated these effects
and reported an observation implying that LgyLRV1+ may
exploit these anti-Leishmania mechanisms to facilitate
its dissemination.

Parasites
LgyLRV1+ and LgyLRV1- parasites were used in this study.
They were obtained following drug treatment of the LRV1+
strain of Lgy M4147 containing a ﬁreﬂy luciferase (ffLUC) gene
integrated stably into the small subunit gene of the ribosomal
RNA locus (LgM4147/SSU : IR2SATLUCb LRV1+) (Kuhlmann
et al., 2017). Parasites were cultured at 26°C in a Schneider’s
medium (SigmaAldrich) supplemented with 10% FCS, 1%
penicillin/streptomycin (P/S), 1% HEPES (Sigma-Aldrich), 0.6
mg/mL of Biopterin (SigmaAldrich) and 5 mg/mL of Haemin
(Sigma-Aldrich).

Materials and methods
Ethics statement
All animal protocols were approved by the Swiss Federal
Veterinary Ofﬁce (SFVO), under the authorization licenses 2113
and 3551. Animal experimentation procedures were conducted
with strict compliance with the ethical guidelines set out by the
SFVO and under inspection by the Department of Security and
Environment of the State of Vaud, Switzerland.

Macrophage extraction and treatment
Bone marrow derived macrophages (BMDMs) were obtained
as follows. Bone marrow was extracted from tibias and femurs of
indicated mice. Macrophages were cultured at 37°C and 5% CO2
in 10 mL of Dulbecco’s modiﬁed Eagle medium (DMEM, Gibco)
supplemented with 10% FCS, 1% P/S, 1% HEPES (Sigma-Aldrich)
and 50 ng/mL murine recombinant M-CSF (Immunotools). After
3 d, half of the initial volume of fresh DMEM was added to the
culture. 3 d later, BMDMs were seeded on culture plates and
incubated overnight. BMDMs were infected with stationary-phase
LgyLRV1+ or LgyLRV1- at a multiplicity of infection (MOI) of 10
parasites per macrophage unless stated otherwise. BMDMs were
also treated with poly (I:C) (In vivogen) at 2mg/ml unless indicated
otherwise, FSL-1 (In vivogen) at 10ng/mL, LPS (In vivogen) at
1mM, IFN-g (BD Biosciences) at 0.1 U/ml or IFN-b (CellScience)
at 500 U/ml.

Mice
Four- to ﬁve-week-old Wild-type mice (WT) (C57BL/
6JOlaHsd) were purchased from Envigo (Netherlands), Tlr3-/mice (B6;129S1-Tlr3 tm1Flv/J) were obtained from Prof. S.
Akira (Osaka University, Japan) via P. Launois (WHO-IRTC,
Lausanne, Switzerland), type I IFN receptor-deﬁcient (Ifnar-/-)
mice (B6.129S2-Ifnar1 tm1Agt/Mmjax) were obtained from
M.Aguet, Swiss Institute of Experimental Cancer Research
(Epalinges, Switzerland), A20ﬂ/ﬂLySMCre/wt mice (A20FL/
LysMCre (Tnfaip3tm1.1Gvl/Lyz2tm1(cre)Ifo)) were obtained
from Prof. M. Pasparakis, University of Cologne (Germany),
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instructions. RNA quality and concentrations were determined
by Fragment Analyzer and Ribogreen QubIT quantiﬁcation,
respectively, and libraries for sequencing were then prepared
at the Lausanne Genomic Technologies Facility (GTF).
Statistical analysis was performed for genes independently in R
(R version 3.5.2). Differential expression was computed with
limma (Ritchie et al., 2015) by ﬁtting data to a linear model.

Mice infection
Stationary phase parasites were injected into the hind footpads
of mice at a concentration of 3 × 106 parasites per footpad in 50 mL
of sterile PBS. Footpad thickness was measured weekly post
infection (p.i.) using a Vernier caliper. In vivo parasites were
quantiﬁed weekly using Bruker Xtreme II as previously described
(Reverte and Fasel, 2019). Ifn-g-/-Inos-/- DKO mice, Ifn-g-/- and
Inos-/- mice in experiments Figures 4C, D, 6 received Dafalgan (1g/
L) diluted in drinking water from week 4.5 p.i. until the end of the
experiments. Inos-/- mice in experiments Figures 4A, B were
sacriﬁced at week 6 p.i. for ethical reasons.

Cytokine measurements
The concentrations of TNF-a (Invitrogen 88-7324-88), IL-6
(Invitrogen 88-7064-88) in collected supernatants from treated
macrophages were determined using enzyme-linked immunosorbent assay (ELISA) following the manufacturer’s instructions.
The plates (Nunc-Immuno) were read on a Synergy HT MultiMode Plate Reader (Biotek Instruments). Wavelength correction
and background signals were subtracted from the absorbance values.

Western blot
Cells after 6, 12- or 24h post-treatment were lysed with. 1.5x
Laemmli’s Sample Buffer. Cell lysates were size-fractionated by
SDS-PAGE and wet-transferred to a nitrocellulose membrane.
The membranes were blocked with 5% milk in Tris buffered
saline with 0.1% tween-20 (TBST), and were incubated with
primary antibody and with appropriate secondary antibody
conjugated to HRP. The membranes were washed with TBST
in between incubations. The immunoblot was revealed by the
enhanced chemiluminescence Western blotting detection, (GE
Healthcare, UK) or with the Fusion Solo S system (Vilber
Lourmat). The ﬁlms (Amersham Hyperﬁlm, GE Healthcare or
SuperRX, Fuji, Japan) were developed using a radiograph (SRX101a, Konica Minolta). Antibodies used for Western blots are
shown in Supplementary Table 2.

Measurements of cytokine secretion in
draining LNs
At indicated time points, lymphocytes were isolated from the
popliteal lymph nodes (LNs) draining the primary lesions. Cells
(5x106/ml) were stimulated with 10 min UV-irradiated LgyLRV1+
or LgyLRV1- promastigotes (1x106/ml) in complete DMEM
medium (Gibco), supplemented with 10% heat-inactivated fetal
bovine serum (FBS), 1% penicillin/streptomycin and 1% HEPES
(Sigma-Aldrich). After 72 hours, IL-17A cytokines were quantiﬁed
in cell-free culture supernatants by ELISA (Invitrogen) following
the manufacturer’s protocol.

mRNA quantiﬁcation using quantitative
real-time PCR

Measurement of nitric oxide

Total RNA was collected by RNAzol RT (Mrcgene). RNA
was reverse-transcribed using the PrimeScript RT Reagent Kit
with gDNA Eraser (Takara; Clontech Inc., USA). RT-PCR was
performed on complementary DNA (cDNA) using primers
described in Supplementary Table 1. Data were acquired using
LightCycler 480 (Roche) and analyzed with the 2-DDCt method.
Data were normalized to L32 expression and samples were
calibrated to the expression of the gene of interest.

Nitric oxide concentrations in culture medium were
measured with the Griess Reagent System (Promega). Samples
(100 µl) were added to the microtiter plates, followed by the
addition of 50 µl of 1% sulfanilamide and 50 µl of 0.1%
naphthylethylenediamine in 2.5% (vol/vol) H3PO4. After
15 min, absorbance was measured with HT Multi-Mode Plate
Reader (Biotek Instruments) at 530 nm and compared with that
of a standard curve of NaNO3. Background signal detected in
not-infected, not-stimulated condition was subtracted from all
experimental conditions.

RNA sequencing of BMDMs and
bioinformatics analysis
High-content microscopy
BMDMs from WT mice were infected with either strain of
Lgy parasites or left untreated for 8 hours. RNA was extracted
using a RNeasy Kit (Qiagen) following manufacturer’s
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prolonged incubation of 48h. Moreover, previously established
high content analysis (Eren et al., 2018) revealed no difference in
parasite burden between LgyLRV1+ and LgyLRV1- infection of
WT as well as iNOS-deﬁcient BMDMs (Figures 1G;
Supplementary Figure 1). These data indicated that in our
experimental conditions LgyLRV1+ infection of BMDMs led
to iNOS induction with no detectable NO and consequently no
impact on parasite burden in vitro.

plates (Falcon Cat No353219 or Ibidi Cat. No 89626). After
overnight incubation, cells were infected with stationary phase
LgyLRV1+ or LgyLRV1- for 48 h. Cells were ﬁxed with freshly
made 4% PFA in PBS (pH 7.4), stained with DAPI (Molecular
Probes) and Alexa 488-Phalloidin (Molecular Probes) then
washed with PBS using a Biotek MultioFlo FX plate washer.
Forty-nine images (737 square, 0.12 mm2) were acquired from
each well using ImageXpress Micro XLS. Cell and parasite
numbers were counted using an automated software program
(MetaXpress) as previously described (Eren et al., 2018).

LgyLRV1+ induced NF-kB signaling
appeared to be insufﬁcient to trigger
potent iNOS expression

Results
LgyLRV1+ induced low level expression
of iNOS in murine BMDMs with no
impact on parasite burden in vitro

Activation of the transcription factor NF-kB and signal
transducer and activator of transcription 1 (STAT-1), and
consequent activation of the iNOS promoter are essential steps
for iNOS induction (Pautz et al., 2010). We therefore tested
whether LgyLRV1+ infection led to phosphorylation of STAT-1
at the S727 residue together with phosphorylation of P65 at
S536. Interestingly, both of the aforementioned transcriptional
factors were activated upon LgyLRV1+ infection, or Poly (I:C)
treatment (Figure 2A), indicating that the transcriptional system
is functional. We then hypothesized that low expression of iNOS
upon LgyLRV1+ infection was due to regulated activation of
either one or both required pathways. To test this hypothesis, we
infected BMDMs with either strain of Lgy and simultaneously
provided additional stimuli for the NF-kB or STAT-1 pathways,
respectively. To activate STAT-1, we used recombinant
interferon beta (IFN-b). FSL-1, a known TLR-2/6 agonist was
used in order to provide potent NF-kB stimulation (Okusawa
et al., 2004). Strikingly, massive levels of iNOS were observed in
the case of a combination of FSL-1 and LgyLRV1+, or FSL-1 and
poly (I:C), but not in BMDMs that were treated with FSL-1 and
infected with the LgyLRV1- counterparts, or that remained
untreated (Figure 2A). In contrast, addition of IFN-b of the
type I IFN family led to elevated levels of iNOS not only in the
case of the LgyLRV1+ and poly (I:C) control, but also in the case
of LgyLRV1- infection and not in uninfected cells (Figure 2A).
We further observed that addition of FSL-1 to LgyLRV1+
infected BMDMs led to the massive increase of Nos2
transcription (Figure 2B), and to detectable levels of nitrites in
the culture medium (Figure 2C). As expected, stimulation with
FSL-1 resulted in activation of NF-kB as indicated by
phosphorylation of P65(S536) and increased production of IL6 and TNF-a in all the conditions (Figures 2A, D, E). Moreover,
enhanced production of iNOS and nitrites by FSL-1 led to a
signiﬁcant decrease in intracellular infection when BMDM were
infected with LgyLRV1+, but not when infected with LgyLRV1(Figure 2F). Various other synthetic TLR-2 agonists had similar
effects on nitrite production when added to LgyLRV1+ infected
BMDMs (Supplementary Figure 2A). Impact on parasite per cell
ratio was also assessed for selected ligand and revealed similar

In order to investigate the impact of LgyLRV1+ and
LgyLRV1- infection on cellular global transcriptome states,
murine bone-marrow derived macrophages (BMDMs) were
incubated with LgyLRV1+ and LgyLRV1- for 8h at multiplicity
of infection (MOI) =5. A global RNAseq analysis was then
performed and the genes expression proﬁles of LgyLRV1+
infected BMDMs were compared to their LgyLRV1- infected
counterparts and to non-infected condition. Several proinﬂammatory genes such as Il6, Cxcl9, Clic5 and Cxcl11 were
strongly upregulated in LgyLRV1+ condition. Strikingly, Nos2
was the most upregulated gene in case of LgyLRV1+ vs noninfected condition and one of the top upregulated when
compared to LgyLRV1- (Figure 1A). To verify this result, WT
murine bone-marrow derived macrophages (BMDMs) were
infected with LgyLRV1+ and LgyLRV1- at a multiplicity of
infection (MOI) =10, left untreated or stimulated with poly (I:
C). Upon indicated time points total mRNAs were isolated and
expression of Nos2 was measured. Infection of BMDMs with
LgyLRV1+ but not with LgyLRV1- led to Nos2 induction
peaking at 12h p.i. The Poly (I:C) control also led to Nos2
expression (Figure 1B). Consequent Western blot analysis
revealed expression of the encoded iNOS protein in the
aforementioned conditions (Figure 1C). Interestingly, despite
observable expression of iNOS on the mRNA and protein level
(Figures 1B, C), conducted Griess assay revealed no nitrites even
after prolonged incubation for 48h. At the same time control
stimulation with LPS and IFN-g, which are known iNOS
provoking stimuli (Chan and Riches, 2001), led to high levels
of iNOS produced at the mRNA (Figure 1D) and protein level
(Figure 1E) and observable levels of nitrites in the supernatants
(Figure 1F). This indicated that LgyLRV1+ infection or poly (I:
C) stimulation led to weak iNOS induction and likely very low
levels of nitrites that are not detectable by the Griess assay as the
observed values do not exceed the background level detected in
the case of the non-infected non-stimulated condition even after
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FIGURE 1

LgyLRV1+ infection induces iNOS expression in murine BMDM. (A) WT BMDMs were infected with LgyLRV1+, LgyLRV1- (MOI 5) or left untreated
for 8h. Total RNA were extracted and full RNAseq analysis was performed. Scatter-plot shows all present genes comparing LgyLRV1+ vs noninfected (x-axis) and LgyLRV1+ vs LgyLRV1- (y-axis), (n = 4). (B) WT BMDMs were infected with LgyLRV1+, LgyLRV1- (MOI 10), stimulated with
poly (I:C) (2 mg/ml), or left untreated, for 2, 6, 12 or 24h. RT-PCR was used to measure L32-normalized Nos2 expression. (C) WT BMDMs were
infected, or treated as in (A). Total cell lysates were analyzed by western blot for iNOS and g-tubulin expression as loading control at indicated
time points. (D) WT BMDMs were infected, or treated as in (A) for 12h. LPS (1mM) and IFN-g (0.1 U/ml) stimulation were used as controls. RT-PCR
was used to measure L32-normalized Nos2 expression. (E) WT BMDMs were infected, or treated as in (C). Total cell lysates were analyzed by
western blot for iNOS and g-tubulin expression as loading control. (F) WT BMDMs were infected, or treated as in (C). Upon 48h supernatants
were collected and levels of nitrites were measured using Griess assay. (G) WT or Inos-/- BMDMs were infected with LgyLRV1+, or LgyLRV1(MOI 10) for 48h. Levels of parasitaemia were analysed using high content microscopy. Data show mean ± SD from a representative of three
independent experiments (A, C, E and F). Representative blots are shown from at least three independent experiments in (C, E) n.i. – noninfected. n.d. - not detected. Data were analyzed using unpaired Student’s t test. Not signiﬁcant (NS), **p < 0.01, and ****p < 0.0001.
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FIGURE 2

External NF-kB activation boosts LgyLRV1+ triggered iNOS induction and rescues BMDMs from infection. (A) WT BMDMs were infected with
LgyLRV1+ or LgyLRV1- (MOI 10), left untreated, or stimulated with poly (I:C) (2 mg/ml) for 12h. Additionally some conditions were treated with
FSL-1 (10 ng/ml), or IFN-b (500 U/ml), or left untreated. Total cell lysates were analyzed by western blot for iNOS, P-STAT1(S727), STAT1, P65, PP65(S536) and g-tubulin expression. (B) WT BMDMs were infected as in (A). RT-PCR was used to measure L32-normilized Nos2 expression.
(C–F) - WT BMDMs were infected as in (A) for 48h. Levels of parasitemia were measured by high content microscopy (F). SNs were collected
and levels of nitrites (C), IL-6 (D) and TNF-a (E) were analyzed by Griess assay and ELISA respectively. Data show mean ± SEM (F), or SD (B–E)
from a representative of three independent experiments. Representative blot is shown from at least three independent experiments in (A). Data
were analyzed using unpaired Student’s t test in F or Sidak’s multiple comparisons (D, E). Not signiﬁcant (NS), **p < 0.01, and ****p < 0.0001. n.i.
– non-infected. n.t. – non-treated. n.d. - not detected.
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insufﬁcient as NF-kB stimulation was required to provoke full
iNOS induction.

results (Supplementary Figure 2B). Taken together these data
suggested that LgyLRV1+ infection of murine BMDMs resulted
in activation of the STAT-1 and NF-kB pathways where the
latter is controlled or insufﬁcient to produce large amounts of
NO to control infection. This can be bypassed by providing
additional NF-kB activating stimuli to provoke robust iNOS
induction, providing evidence that in LgyLRV1+ infection, iNOS
production is functional but strictly controlled.

LRV1-TLR3-IFNAR mediated iNOS did
not control LgyLRV1+ infection in vivo
To further understand the impact of LRV1-TLR3-IFNAR
induced iNOS on the course of the disease in vivo, we infected
iNOS-deﬁcient mice and their WT counterparts with LgyLRV1+
parasites. Interestingly, no difference in footpad swelling, or
parasite burden, was observed in the ﬁrst three to four weeks
of infection (Figures 4A, B; Supplementary Figure 3A) As
expected iNOS-deﬁcient mice showed increased levels of
footpad swelling and parasitemia around week 4 post
infection. After this point WT mice showed decrease in
footpad swelling and infection was resolved around week 8 p.i.
This can be explained by actions of the Th1 mediated adaptive
response that leads to production of IFN-g and consequent
control of infection via iNOS (Sacks and Noben-Trauth,
2002). It was, however, not possible to fully determine the
moment when CD4+ Th1 cells began to produce IFN-g
leading to iNOS production. Moreover, NK cells are a major
source of IFN-g during innate phase long before the
development of an adaptive response (Biron and Brossay,
2001). Thus, in order to investigate the exact impact of iNOS
induced by LgyLRV1+ and not induced by other stimuli, we
needed to exclude the role of IFN-g, as the iNOS inducer. With
this in mind we generated Ifn-g-/-Inos-/- double knock out (DKO)
mice. We then infected DKO and Ifn-g-/- single deﬁcient mice
with LgyLRV1+ parasites. In IFN-g-deﬁcient mice, the LRV1TLR3-IFNAR axis should remain the predominant signaling axis
to induce iNOS. Strikingly both genotypes responded to
infection in a similar pattern with almost no signiﬁcant
difference in footpad swelling or parasite burden (Figures 4C,
D; Supplementary Figure 3B). These ﬁndings showed that iNOS
triggered by LgyLRV1+ did not control infection in vivo.

LgyLRV1+ infection induced iNOS
expression in murine BMDMs via type I
IFN signaling
We previously reported that LgyLRV1+ infection leads to
production of type I IFNs (Ives et al., 2011). iNOS is known to
be among the molecules produced in response to type I IFN
stimulation (Mattner et al., 2004). Thus, we decided to
evaluate if LRV1-induced iNOS was mediated by a second
wave of signals arising from type I IFN binding to its receptor
(IFNAR). Indeed, macrophages, deﬁcient for IFNAR failed to
produce iNOS while cells lacking TLR3 were able to express
this enzyme after combined stimulation with recombinant
IFN-b and FSL-1 (Figure 3A). Consistent with this result, no
nitrites were detected in the culture medium of Ifnar-/- cells,
while IFN-b combined with FSL-1 treatment led to nitrite
production in Tlr3-/- cells and WT cells infected with LgyLRV1
+ and treated with FSL-1. The same was observed in case of
cells that were treated with poly (I:C), or IFN-b in
combination with FSL-1, but not alone (Figures 3B, C). We
also veriﬁed that LgyLRV1+ triggered iNOS and nitrite
production relied on the presence of LRV1 in parasites and
on an LRV1-TLR3-IFNAR signaling axis, and did not depend
solely on parasites. WT BMDMs were infected with LgyLRV1parasites and treated with FSL-1. Simultaneously various
concentrations of poly (I:C) were added. Levels of nitrites
were detected in a dose-dependent manner in conditions
where cells were also treated with FSL-1 (Figure 3D). We
then hypothesized that the secreted type I IFNs could act on
the neighboring non-infected cells and together with external
NF-kB activating stimuli could lead to iNOS induction and
production of NO. To test this hypothesis, we collected
supernatants (SNs) from LgyLRV1+ infected WT BMDMs,
supplemented them with FSL-1 and added them to naive WT,
or Ifnar-/- BMDMs (Figure 3E). As expected iNOS production
and nitrites were observed only in WT cells that were treated
with SNs of cells infected with LgyLRV1+, or treated with poly
(I:C), and not in Ifnar-/- cells, or WT cells that were treated
with SNs obtained from untreated cells, or from BMDMs
infected with LgyLRV1- (Figures 3F, G). These data indicated
that LgyLRV1+ infection led to iNOS induction via the LRV1TLR3-IFNAR pathway in an auto- and a paracrine manner.
Importantly, actions of type I IFNs were indispensable but
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Leishmania guyanensis suppressed type I
IFN activated iNOS expression by
inducing A20 and minimizing
NF-kB signaling
We recently showed that both LgyLRV1+ and LgyLRV1strains trigger A20 production (Hartley et al., 2018), an early
NF-kB induced gene that is known to be a major negative
feedback regulator of NF-kB-mediated inﬂammation
(Coornaert et al., 2009; Catrysse et al., 2014). Therefore, we set
to investigate the impact of LgyLRV1+ induced A20 on NF-kB
suppression and consequent downregulation of iNOS. Full A20
knockout mice rapidly become cachectic and died within a few
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FIGURE 3

LgyLRV1+ triggered type I IFNs are necessary but not sufﬁcient in order to induce iNOS in an auto- and paracrine manner. (A) WT, Tlr3-/- or
Ifnar-/- BMDMs were infected with LgyLRV1+ or LgyLRV1- (MOI 10), stimulated with poly (I:C) (2 mg/ml), FSL-1 (10 ng/ml), IFN-b (500 U/ml),
alone or in combination, or left untreated for 12h. Total cell lysates were analyzed by western blot for iNOS and g-tubulin expression. (B, C) WT,
Tlr3-/- or Ifnar-/- BMDMs were treated as in (A) for 48h. SNs were collected and levels of nitrites were measured using Griess assay. (D) WT
BMDMs were infected with LgyLRV1- (MOI 10), treated with FSL-1 (10 ng/ml) alone or in combination. Except one, all conditions were treated
with poly (I:C), with one of eight two-fold serial dilution concentrations ranging from 2 to 0.015 mg/ml. Upon 48h SNs were collected and levels
of nitrites were measured using Griess assay. (E) scheme depicting experiments performed in (F, G). (F, G) WT BMDMs were infected with
LgyLRV1+ or LgyLRV1- (MOI 10), stimulated with poly (I:C) (2 mg/ml), or left untreated. Upon 6h, SNs were collected, ﬁltered with 22 um ﬁlter,
supplemented with FSL-1 (10 ng/ml) and added to the fresh set of untreated WT and Ifnar-/- BMDMs. Upon 24h, SNs from treated BMDMs were
collected and levels of nitrites were measured using Griess assay (G). Total cell lysates were analysed by western blot for iNOS and g-tubulin
expression (F). Data show mean ± SD from a representative of three independent experiments (B, C, F). Representative blots are shown from at
least three independent experiments in (A, F). the following: ****p < 0.0001, n.i. – non-infected. n.t. – non-treated. n.d. - not detected.
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FIGURE 4

Type I IFNs mediated iNOS does not control LgyLRV1+ infection in vivo. Hind footpads of WT, Inos-/-, Ifng-/- and Ifng-/-Inos-/- DKO mice were
infected with 3 × 106 LgyLRV1+. (A, C) – graphs display weekly measurements of footpad swelling. (B, D) Parasite burden was determined after
infection by bioluminescence imaging. Data show mean ± SEM from representative experiments (n = 4–5 mice) of at least three independent
experiments. Each data point on (B, D) represents one footpad. Statistical signiﬁcance is calculated using two-way ANOVA analysis with
Bonferonni’s test (A). Not signiﬁcant (NS), *p < 0.05 and ***p < 0.001.

Ifn-g-/-Inos-/- double deﬁcient mice
showed delayed formation of metastatic
nodules upon LgyLRV1+ infection

weeks of age, as a result of uncontrolled inﬂammation in several
organs (Lee et al., 2011). Thus, we used BMDMs obtained from
A20ﬂ/ﬂLysMCre+/wt mice. These animals have a deletion of A20
in the myeloid lineage. A20ﬂ/ﬂLysMCrewt/wt mice were used as
littermate control. In line with reported previously results
(Hartley et al., 2018), both strains of Lgy induced A20
expression, with LgyLRV1+ showing stronger expression
(Figure 5A). When infected with either strain of Lgy, A20ﬂ/
ﬂ
LysMCre+/wt cells showed stronger signs of inﬂammation,
including higher levels P-P65(S536) and increased production
of IL-6 and TNF-a (Figures 5A, D, E). As expected, A20deﬁcient cells that were infected with LgyLRV1+, but not
LgyLRV1- parasites, showed stronger expression of iNOS
(Figure 5A). Moreover, signiﬁcant amounts of nitrites were
detected in the culture medium as well as a decrease in
parasite per cell ratio (Figures 5B, C). These data indicated
that LgyLRV1+ infection led to A20 activation which in turn
limited NF-kB activation, therefore minimizing LRV1-TLR3IFNAR mediated iNOS induction and parasite death.
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As described above Ifn-g-/-Inos-/- DKO mice showed no
difference in footpad swelling or parasite load compared to
IFN-g deﬁcient mice (Figures 4C, D). This suggested that
LRV1-TLR3-IFNAR triggered iNOS had very little impact on
parasite control. Surprisingly, double deﬁcient mice showed
fewer metastatic nodules on the tail compared to IFN-g
deﬁcient mice. Nodules appeared less severe (Figure 6A),
smaller in size and their formation was delayed by at least one
week (Figure 6C). X-ray imaging also revealed that formation of
nodules was accompanied by partial bone destruction and
occurred earlier than its visible appearance on the tail
(Figure 6B enlarged segment). We previously reported that
IFN-g deﬁcient mice produce large amounts of IL-17A upon
LgyLRV1+ infection and that this cytokine governs the
formation of the metastatic nodules as evidenced by its
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FIGURE 5

Lgy infection minimizes iNOS expression by suppressing NF-kB via A20 induction. (A) WT or A20ﬂ/ﬂLySMCre/wt (KO) BMDMs were infected with
LgyLRV1+, or LgyLRV1- (MOI 10), stimulated with poly (I:C) (2 mg/ml), or left untreated for 12h. Total cell lysates were analysed by western blot
for iNOS, A20, P-P65(S536), P65 and g-tubulin expression. (B–E) - WT or (KO) BMDMs were treated as in (A) for 48h. Levels of parasitemia were
measured by high content microscopy (C). SNs were collected and levels of nitrites (B), IL-6 (D) and TNF-a (E) were analyzed by Griess assay
and ELISA, respectively. Data show mean ± SD from a representative of three independent experiments (B–E). Representative blot is shown
from at least three independent experiments in (A). Statistical signiﬁcance is calculated using unpaired Student’s t test in (C) and Tukey’s multiple
comparison test in (D) and (E). Not signiﬁcant (NS), ***p < 0.001, ****p < 0.0001. n.i. – non-infected. n.t. – non-treated. n.d. - not detected.
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FIGURE 6

Ifng-/-Inos-/- mice showed delayed metastasis formation compared to Ifng-/- upon LgyLRV1+ infection. Hind footpads of Ifng-/- and Ifng-/Inos-/- DKO mice were infected with 3 × 106 stationary phase promastigotes of LgyLRV1+. (A) Photographic images of representative mice
showing metastatic lesions on the tail at week 8 post infection. Arrow heads indicate the metastatic nodules. bone destruction. (B) X-ray images
of representative mice showing metastatic lesions on the tail at indicated time points. Arrow heads and enlarged image indicate bone
destruction. (C) Number of metastatic lesions per mouse. (D–G) Ifng-/- and Ifng-/-Inos-/- DKO mice were infected into hind foot pads with 3 ×
106 stationary phase promastigotes of LgyLRV1+ or LgyLRV1- as indicated. At 6- and 8-weeks post infection, lymphocytes were extracted from
popliteal LNs draining the primary lesion and then re-stimulated ex vivo with UV-irradiated promastigotes of LgyLRV1+ or LgyLRV1- respectively.
Upon 72h, IL-17A secretion was quantiﬁed by ELISA in cell-free supernatants. Data show mean ± SEM from three independent experiments with
at least 3 mice per group for LgyLRV1+ infection and from two independent experiments with at least 3 mice per group for LgyLRV1- infection.
Statistical signiﬁcance is calculated using 2-way Anova test in (C) and Student’s t test in (D–G). Not signiﬁcant (NS), **p < 0.01, and ***p < 0.001.

No difference was observed at a later time point (week 8 p.i.)
(Figure 6E) as well as when mice were infected with LgyLRV1parasites (Figures 6F, G). Although not signiﬁcant, we observed
a tendency showing fewer parasites in the tails of ifn-g-/-inos-/-

genetical deletion or chemical inhibition that dramatically
reduced the number of metastatic nodules (Hartley et al.,
2016). Ifn-g-/-Inos-/- DKO mice showed decreased production
of IL-17A in the draining lymph nodes at week 6 p.i. (Figure 6D).
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mice compared to their ifn-g-/- counterparts (Supplementary
Figure 4). These data suggested that NO produced downstream
of the LRV1-TLR3-IFNAR-iNOS signaling axis might affect
secretion of IL-17A and thus impact formation of secondary
metastatic lesions.

expression. However, LRV1-triggered iNOS failed to control
infection in vitro and in vivo. We further showed that production
of iNOS in response to LRV1 required the action of type I IFNs,
that have been previously shown to govern the exacerbated
disease phenotype (Rossi et al., 2017). We then investigated
the strategy employed by the parasites to evade death by type I
IFN-mediated iNOS. We showed that Leishmania suppressed
NF-kB activation, another pathway required for a robust iNOS
induction. Finally, we report an observation suggesting that low
levels of LRV1-triggered iNOS and, the production of NO that
might correlate with parasite propagation and metastasis. Our
ﬁndings provide the link between disease exacerbating LRV1elicited type I IFNs and IL-17A mediated metastasis, occurring
in the absence, or in the presence of low levels of protective
IFN-g.
Type I IFNs that are mainly associated with innate immune
response are also known to be upstream of iNOS induction.
Their role in pathogenesis of leishmaniasis is controversial and,
most likely, depends on the species of Leishmania. In particular,
IFN-b has been shown to be protective against Leishmania
major (Lm) of the Leishmania subgenus. This effect has been
associated with iNOS induction (Diefenbach et al., 1998;
Mattner et al., 2004). On the other hand, species of the
Leishmania Viannia subgenus such as Lbr and Leishmania
amazonensis (Lam) beneﬁt from the actions of type I IFNs in
an NO-independent manner. In the latter case, type I IFNs led to
up-regulation of superoxide dismutase I (SOD1) and consequent
reduction of parasiticidal superoxide (Khouri et al., 2009). We
recently reported that LRV1-induced type I IFNs contributed to
disease progression in the case of Lgy infection (Rossi
et al., 2017).
The exact mechanism leading to type I IFN-mediated iNOS
induction is based on cooperation of two transcriptional
pathways and has been well characterized (Farlik et al., 2010;
Wienerroither et al., 2015). On the one hand it involves the type
I IFN pathway, whereby ligation of IFNAR leads to
phosphorylation of STAT1 and STAT2 by the receptorassociated Janus tyrosine kinases (JAK). The tyrosinephosphorylated STATs form heterodimers and also bind to
the interferon regulatory factor 9 (IRF9). This results in the
formation of a trimeric complex, known as interferonstimulated gene factor 3 (ISGF3). ISGF3 alone may be both
necessary and sufﬁcient for the transcription of some interferonstimulated genes (ISGs). However, often and depending on a
promoter, it requires input from additional signaling pathways
such as NF-kB (Levy and Darnell, 2002). This becomes the
second arm of the aforementioned transcriptional cooperation,
which is necessary for iNOS induction. NF-kB binds to the gene
promoter following induction by PRR signaling, this in turn
leads to the recruitment of various proteins involved in the
formation of a bigger transcriptional complex. Consequent
assembly and binding of ISGF3 leads to the ligature of
previously recruited proteins to their binding partners and

Discussion
Although transmission of most CL-causing Leishmania spp
is zoonotic by nature (Gramiccia and Gradoni, 2005),
generations of man-made impact on environmental setting
and urbanization have led to the disease being acquired in
various types of human settlements (Reithinger et al., 2019).
This led to wider geographical distribution and increased
incidence of human cases that were ﬁrst described as early as
7th century BC (Cox, 2002; Zink et al., 2006). Threatening
humanity for thousands of years, Leishmania parasites have
excelled at survival and propagation. In a long lasting evolutional
race they have developed various mechanisms allowing them to
evade and subvert defensive mechanisms of the host (AguirreGarcia et al., 2018; Rossi and Fasel, 2018). One strategy lies
within the cooperative relationship with dsRNA viruses such as
LRV1 that are harbored inside the parasite. Innate immune
recognition of LRV1 within Lgy leads to exacerbation of the
disease (Ives et al., 2011), prolonged survival of the host cell and
persistence of intracellular parasites (Eren et al., 2016) that in
turn facilitates parasite dissemination and metastasis (Hartley
et al., 2016). Similarly, infection with exogenous viruses can
seriously worsen the course of disease, promote metastasis and
relapse of leishmaniasis caused by LRV1-free Lgy (Rossi
et al., 2017).
An indispensable role of iNOS in immune protection against
leishmaniasis in mice has been long known (Wei et al., 1995),
and widely reviewed (Bogdan, 2015; Olekhnovitch and Bousso,
2015). Host defense against leishmaniasis primarily relies on the
actions of a mounted adaptive immune response. Several weeks
upon infection, C57BL/6 mice develop a strong type 1 helper
(Th1) CD4+ T cell response. These mice are able to efﬁciently
control infection whereas BALB/c mice develop a type 2 helper
(Th2) CD4+ T cell response and fail to recover. These
observations provided evidence that immune protection
against leishmaniasis is governed by actions of CD4+ T cells
(Sacks and Noben-Trauth, 2002). Upon polarization, CD4+ T
cells migrate to the lesion where they accumulate (Filipe-Santos
et al., 2009). Consequently, they begin secreting large amounts of
IFN-g of the type II IFN family. Sensed by macrophages, this
cytokine triggers expression of iNOS which in turn generates
high amounts of NO leading to parasite elimination in an autoand paracrine manner (Liew et al., 1991; Olekhnovitch and
Bousso, 2015).
In this study, we revealed that one of the major impacts of
LRV1 recognition by TLR3 was up-regulation of iNOS
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TNFAIP3, also known as A20, is a ubiquitin-modulating
enzyme known to regulate NF-kB activity by removing the K63linked polyubiquitin chains from RIPK1 and thus interfering
with its interaction with IKK-g (Karin and Greten, 2005), a
crucial element in the classical NF-kB pathway. Several studies
reported that Leishmania infection is able to promote A20
induction and thus control NF-kB activity and subsequently
evade iNOS induction (Srivastav et al., 2012; Gupta et al., 2017).
We recently showed that both, LgyLRV1+ and LgyLRV1- strains,
induce A20 expression (Hartley et al., 2018). Notably, A20
production was more potent in the ﬁrst hours of infection and
was intensiﬁed in case of LgyLRV1+. This, together with the fact
that A20 expression is itself under the control of NF-kB
(Catrysse et al., 2014) suggested two waves of signaling. Firstly,
infection with LgyLRV1+ led to production of type I IFN and
activation of NF-kB that consequently led to A20 induction.
Secondly, A20 suppressed NF-kB activity before the LRV1triggered type I IFNs were sensed by IFNAR and led to
formation of ISGF3 and induction of iNOS. To test this
hypothesis we used BMDMs obtained from mice conditionally
lacking A20 in myeloid lineage as full A20 knockout mice
rapidly become cachectic and died within a few weeks of age,
as a result of uncontrolled inﬂammation in several organs (Lee
et al., 2011). We revealed that, indeed, cells lacking A20
expressed higher amounts of pro-inﬂammatory cytokines,
iNOS and NO and were able to resist to LgyLRV1+ but not to
LgyLRV1- infection (Figures 5A–E). While we could prove this
hypothesis in vitro, in vivo experiments were impossible for
ethical reasons as A20 deﬁcient mice spontaneously developed
polyarthritis over time (Vande et al., 2014) and any parasitic
infection would extremely aggravate this effect. Taken together,
we concluded that LgyLRV1+ parasites efﬁciently evaded LRV1TLR3-IFNAR-triggered iNOS induction by activating A20
expression and thus suppressing NF-kB which is also required
for potent iNOS production. Therefore, we provided, for the
ﬁrst-time evidence of how a symbiotic relationship between the
protozoan parasite Leishmania and its dsRNA virus, LRV1, can
lead to potentially mutually-detrimental effects of this
cohabitation and how this mechanism was circumvented.
The exact mechanisms that govern parasite dissemination
processes in MCL and DCL complications of the cutaneous form
of the disease are largely unknown and the role of LRV1 is still
controversial. Host-related immunological and environmental
as well as parasite species-speciﬁc factors all have been linked to
mediation of infectious metastasis, suggesting that this process is
multifactorial and depends on a large number of players and
their interaction (Hartley et al., 2014). LRV1, nested within Lgy
and Lbr has been shown to be one of such factors and, perhaps,
the main one among those associated with the parasite. In vivo
experiments showed that presence of LRV1 strongly enhances
metastatic activity of the parasites in hamsters and mice
(Martinez et al., 2000; Ives et al., 2011; Hartley et al., 2016)
although the latter were immunocompromised. LRV1 was found

later recruitment of complexes containing the RNA polymerase
II (Pol II) (Farlik et al., 2010; Wienerroither et al., 2015). Our
data lied within this mechanism whereby LRV1-induced type I
IFNs could be sensed by BMDMs in an autocrine and paracrine
manner. However, the NF-kB pathway appeared to be
controlled, or insufﬁcient to lead to strong iNOS induction in
vitro. Our data demonstrated that the above described system
was not impaired functionally as additional NF-kB stimulation
via TLR-2/6 signaling boosted LRV1-mediated iNOS
induction (Figure 2).
It is evident that the overall impact of the LRV1-TLR3IFNAR signaling axis beneﬁted disease progression and
contributed to the pathological phenotype (Rossi et al., 2017).
iNOS can also be induced by activation of TLR4 (Abdul-Cader
et al., 2016), or as shown by our data, by combined ligation of
TLR2 and TLR3 (Figures 3A, B). We previously demonstrated
that TLR2 and TLR4 do not play major roles in the innate
response to Lgy (Ives et al., 2014). This was also supported by
another study which showed no protective role of TLR2 in
response to Lbr, another species of the Leishmania Viannia
subgenus (Vargas-Inchaustegui et al., 2009). These ﬁndings were
opposite to what is known in regard to TLR2 function against
the Leishmania subgenus and Lm in particular (Halliday et al.,
2016). Observed species-speciﬁc differences can be explained by
the fact that Leishmania parasites express different types, and up
to 10-fold less lipophosphoglycan (LPG), a surface molecule,
which is known to activate TLR-2 (Muskus et al., 1997; De Assis
et al., 2012). Taken together these results lead to the assumption
that the symbiotic partnership between Leishmania parasites
and LRV1 occurred preferentially in those parasite species where
the chances to induce parasitotoxic iNOS were minimized and
thus allowed beneﬁcial effects of co-habitation that overweighed
the detrimental ones.
As described above, BMDM infection with LgyLRV1+ alone led
to very weak iNOS production at the protein level and no detectable
nitrites in the culture medium that did not have an impact on the
level of intracellular infection in vitro (Figures 1E–G). This
observation combined with the in vivo data (Figures 4C, D) led
us to hypothesize that LgyLRV1+ parasites developed a strategy to
minimize type I IFN induced iNOS, allowing them to beneﬁt from
other effects of type I IFN signaling (Rossi et al., 2017). As we were
able to greatly enhance LgyLRV1+ induced iNOS induction by
providing additional inﬂammatory stimuli (Figures 2A–F), we
assumed that the iNOS-coping strategy of LgyLRV1+ lied within
suppression of NF-kB activation. While artiﬁcial in our in vitro
setting, such additional inﬂammatory stimuli can naturally arise
from harmless commensals present in the skin and known to
impact inﬂammatory reactions (Naik et al., 2012; Belkaid and
Tamoutounour, 2016; Gimblet et al., 2017) or from sandﬂy gut
microbiota egested together with the parasites (Dey et al., 2018).
Such immunologically cross-reactive environment would serve as
an additional stimulus for a parasite to evolutionary develop iNOSmitigation mechanisms.
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correlates well with the role of NO in the ﬁeld of cancer
metastasis. Pro-metastatic effects of NO are speciﬁcally
attributed to the low concentrations (Tozer et al., 1997; FelleyBosco, 1998; Cheng et al., 2014), while high concentrations have
an opposite, anti-metastatic and tumoricidal effect (Juang et al.,
1995; Dong et al., 1994). Our data lies within these
concentration-dependent effects as LRV1-TLR3-IFNAR
induced iNOS and subsequently produced NO are barely
detectable in in vitro experiments and their amounts are
insufﬁcient to control the infection.
In our experiments we observed that depletion of the Nos2
gene in addition to Ifn-g-/- leads to decreased IL-17A production
and delayed metastasis. There is little and contradicting evidence
of a direct cause-effect association between iNOS and IL-17A.
While some studies show the positive correlation between iNOS
and stability of Th17 cells as well as production of IL-17A
(Obermajer et al., 2013; Zhong et al., 2018), others show that NO
negatively regulates these processes (Niedbala et al., 2011).
While these discrepancies might also relate to the magnitude
of NO, it is important to mention that we were unable to detect
the exact T cell population that was responsible for IL-17A
production in LgyLRV1+ infection (Hartley et al., 2016). Thus,
the exact relation between LRV1-triggred iNOS and IL-17A
production in LgyLRV1+ infection of Ifn-g-/- mice is still unclear
and requires further investigation.
In conclusion we demonstrated that LRV1-bearing
Leishmania guyanensis induced A20 to minimize NF-kB
activation and evaded death via iNOS induced by its viral
endosymbiont. Additionally, we report that low amounts of
NO induced as a result of the LRV1-TLR3-IFNAR signaling
axis might correlate with the amounts of metastasis mediating
IL-17A and thus impact parasite metastasis in an
immunocompromised setting.

in various clinical isolates of Lgy and Lbr from Neotropical
regions and was linked to the metastatic phenotype in patients
(Cantanhêde et al., 2015), although this association was not
exclusive (de Oliveira Ramos Pereira et al., 2013; Saberi et al.,
2019; Valencia et al., 2022). These discrepancies further suggest
that host-related factors such as the strength of the immune
system seem to play a major role in mediating parasitic
metastasis. We recently reported that patients, suffering from
chronic forms of leishmaniasis caused by Lgy had decreased
levels of IFN-g and high levels of the inﬂammatory cytokine IL17A. Moreover, these ratios were strictly dependent on whether
parasites contained LRV1 or not (Hartley et al., 2016). Based on
this we earlier established a murine model to study metastatic
leishmaniasis and observed that absence, or low levels of IFN-g,
was a prerequisite for the metastatic effect whilst presence of
LRV1 signiﬁcantly intensiﬁed it. In the absence of IFN-g, levels
of IL-17A in the draining lymph nodes were highly elevated and
seemed to govern the development of metastasis as genetic
deletion or pharmacological blockade of this cytokine
abolished the effect (Hartley et al., 2016). Similarly,
involvement of IL-17A in metastatic processes is well
documented in cancer research (Coffelt et al., 2015; Song et al.,
2020; Zhao et al., 2020).
In our study we wished to determine whether LRV1-TLR3IFNAR induced iNOS is able to control Leishmania infection in
vivo. As STAT-1 activation, required for Nos2 transcription,
could be induced by either type I or type II IFN signaling, we
needed to exclude the latter in order to answer the
aforementioned question. Thus, we used IFN-g-deﬁcient mice,
in which the LRV1-TLR3-IFNAR axis should remain the
predominant signaling path to induce iNOS. Additionally, we
generated Ifn-g-/-Inos-/- DKO mice that would lack iNOS and
have the same genetic background. Both genotypes responded to
infection in a similar pattern with no difference in footpad
swelling or parasite burden (Figures 4C, D) and thus
conﬁrming the previously stated conclusion that LRV1triggered iNOS is insufﬁcient to control the infection due to
suppression of NF-kB by parasite-induced A20. However, the
difference that we observed was in the formation of metastatic
lesions on the tail that should arise in IFN-g-deﬁcient mice as
described above (Hartley et al., 2016). DKO mice developed less
severe nodules on the tail and their formation was delayed by 1-2
weeks (Figures 6A-C). In line with this delay we observed that
DKO mice had decreased levels of metastasis-mediating IL-17A
in the draining lymph nodes compared to Ifn-g-/- deﬁcient mice
(Figure 6D). This effect was transient as at the later time point no
signiﬁcant difference was observed (Figure 6E). This is consistent
with the appearance of the metastatic nodules on the tails
(Figure 6C). Although, we could not observe signiﬁcant
reduction of the parasite load on the secondary sites (tail)
(Supplementary Figure 4), our ﬁndings suggest that LRV1triggred iNOS and the NO produced by it may have prometastatic effects in IFN-g-deﬁcient mice. This observation
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